Zenith TX2 Pro-Form G53447Recalls & reported problems
William Cook Europe ApS · Zenith TX2, TAA Endovascular Graft with Pro-Form, Proximal Tapered Component · Class 3 · Implant
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10827002534473), received between Oct 9, 2019 and Oct 18, 2019 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Migration” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Migration2
Patient problems
- No Information2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryOct 18, 2019Migration; Migration
DESCRIPTION OF EVENT ACCORDING TO STUDY: ON (B)(6) 2014, THE PATIENT RECEIVED ZTEG-2PT-36-197-PF-US (LOT # E3219029) UNDER GENERAL ANESTHESIA. A CODA-2-10.0-35-120-40 (LOT # 4931829) MOLDING BALLOON WAS USED WITHOUT DIFFICULTY OR COMPLICATION. NO ADVERSE EVENTS WERE REPORTED RELATED TO THE IMPLANT PROCEDURE. THE PATIENT HAS BEEN FOLLOWED BY A SERIES OF CTS (DATES: (B)(6) 2014, (B)(6) 2015, (B)(6) 2017, (B)(6) 2018) WITH NO DEVICE RELATED ISSUES REPORTED. A (B)(6) 2019 CT REVEALED CAUDAD MIGRATION. CORE LAB NOTED, ¿CAUDAD (AT THE PROXIMAL END). L2 HAS INCREASED MORE THAN 10MM, AND THE 3D RECONSTRUCTIONS SHOW A CHANGE IN THE RELATIONSHIP OF THE DEVICE TO CALCIFICATION IN THE AORTIC WALL.¿ CORE LAB ALSO NOTED, ¿L2 HAS INCREASED MORE THAN 10MM, AND THE 3D RECONSTRUCTIONS SHOW A CHANGE IN THE RELATIONSHIP OF THE DEVICE TO CALCIFICATION IN THE AORTIC WALL. THE DEVICE HAS PARTIALLY OVERLAPPED THE 3RD AND 4TH STENTS OVER TIME AS ANGULATION DEVELOPED, WHICH APPEARS TO HAVE PULLED THE PROXIMAL ASPECT OF THE DEVICE IN A CAUDAD DIRECTION. L6 IS NOW ALSO >10MM INCREASED OVER THE 1 MONTH TIME POINT. IT IS NOT CLEAR THAT THIS IS DUE TO MIGRATION, AS NO DEFINITE ANATOMIC MARKERS ARE IDENTIFIED FOR
Patient problems: No Information
MAUDE report 9209153 ↗MalfunctionOct 9, 2019Migration; Migration
NO ADDITIONAL INFORMATION REGARDING THE PATIENT AND/OR EVENT HAS BEEN RECEIVED SINCE THE PREVIOUS MEDWATCH REPORT WAS SENT.
Patient problems: No Information
MAUDE report 9171303 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page